NKBIO CO LTD has a total of 11 patent applications. Its first patent ever was published in 2008. It filed its patents most often in Republic of Korea, China and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and machines are CHINA AGRICULTURAL VET BIO SCIENCE AND TECH CO LTD, KAWAOKA YOSHIHIRO and MEDRA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 6 | |
#2 | China | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Peptides | |
#4 | Unspecified technologies | |
#5 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Hong Seon Min | 4 |
#2 | Kim Su Dong | 3 |
#3 | Yoon Sung Hwa | 2 |
#4 | Choi Byoung In | 2 |
#5 | Kim Soo Ki | 2 |
#6 | Lee Dong Ouk | 2 |
#7 | Min Hong Sun | 2 |
#8 | Ouk Lee Dong | 2 |
#9 | In Choi Byoung | 2 |
#10 | Baek Young Seok | 2 |
Publication | Filing date | Title |
---|---|---|
KR101039843B1 | A medium composition for cultivating self activated lymphocyte and the cultivation method using the same | |
KR20110121072A | The invention of substances preventing skin, lung, stomach and uterine cancers by inhibiting the grawth of cancer cell in a humanbody | |
KR20110121088A | Composition for immunity reinforcement in weakened human body and damaged organ through disease treatment | |
KR20110117277A | Composition development for induced human immune cell's activity : igm, igg, macrophage, plaque-forming cell and nk cell | |
KR20090127974A | A medium composition for cultivating self activated lymphocyte | |
KR20090127973A | A method for cultivating self activated lymphocyte |